Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 30 Carcinoma, Non-Small-Cell Lung 30 Lung Neoplasms 23 Head and Neck Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 15 Lymphoma 15 Gliosarcoma 15 Central Nervous System Neoplasms 14 Sarcoma 12 Esophageal Neoplasms 12 Rectal Neoplasms 10 Glioma 10 Leukemia 9 Breast Neoplasms 9 Brain Neoplasms 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 8 Lymphoma, Follicular 7 Esophageal Squamous Cell Carcinoma 7 Neoplasms 6 Melanoma 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell, Marginal Zone 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Astrocytoma 5

Interventions

Ipilimumab 5 Nivolumab 4 pembrolizumab 3 sargramostim 2 fludarabine 2 binimetinib 2 aldesleukin 2 Interleukin-2 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Cyclophosphamide 2 trametinib 1 tebentafusp 1 sotrastaurin 1 montanide ISA 51 1 incomplete Freund's adjuvant 1 glembatumumab vedotin 1 fludarabine phosphate 1 entrectinib 1 Valproic Acid 1 Tramadol 1 Thalidomide 1 Temozolomide 1 Solutions 1 Ruthenium-106 1 Radiotherapy 1 RNA, Messenger 1 Protein Kinase C 1 Pharmaceutical Preparations 1 Melphalan 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Uveal Melanoma × Radiotherapy × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡